Synergistic beeswax-based nano-formulation for enhanced chronic wound healing and antibacterial potency
Abstract
), preserving >80% fibroblast viability at therapeutic doses. This multimodal platform concurrently addresses infection control (including biofilm resistance), analgesia, tissue regeneration, and controlled delivery, offering a transformative strategy for chronic wound management.
Fields of Study & Subjects
Wound Healing and Treatments
Bee Products Chemical Analysis
Silk-based biomaterials and applications
Publication details
- Journal / source
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 16
- Issue
- 12
- Pages
- 10822–10846
- Publication date
- 1 January 2026
- Language
- EN